Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00056576 · ClinicalTrials.gov registry record · Phase 3
Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy
A Phase 3 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 3
- Development phase
- 165
- Enrollment target
NCT00056576 is a Phase 3 study that has completed, run by Eisai. The registered enrollment target is 165 participants.
The verdict
NCT00056576, a Phase 3 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 165 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases.
Interventions
- DRUG Zonisamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2002-02 |
| Est. Completion | 2004-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00056576
The ClinicalTrials.gov registry entry for NCT00056576 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zonisamide is the first listed.
NCT00056576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00056576 about?
NCT00056576 is a clinical study titled "Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy". The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases.
What is the current status of trial NCT00056576?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 165 participants. The study started on 2002-02. Estimated completion is 2004-10.
What interventions are being tested in trial NCT00056576?
The interventions under investigation include: Zonisamide (DRUG).
Who is sponsoring clinical trial NCT00056576?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.